This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
This webinar will discuss recent advances in immunotherapy clinical trial designs, especially those incorporating novel combinations, that are helping to improve patient experiences and accelerate the development of more cures.
This webinar will share some of the most important facts patients need to know about immunotherapy.
This webinar will explore how the different branches of the immune system works, and how we’re tapping into its immense and diverse capabilities in order to conquer all forms of cancer via a wide variety of immunotherapy approaches.
Dr. E. John Wherry discusses what might lie ahead for the field in 2022—and what it means for patients.
Drs. Lewis Lanier and Oscar Aguilar of UCSF discuss new horizons in cellular therapy to fight cancer.
Three CRI ImmunoAdvocates discuss redefining and navigating their lives after cancer immunotherapy.
By monitoring a variety of factors, especially at the genetic and genomic levels, blood tests may give doctors deep insights into a person’s cancer and their immune health.
Dr. Kunle Odunsi of Roswell Park discusses what might lie ahead for the field in 2021—and what it means for patients.
Discover the microscopic organisms that inhabit our bodies and new microbiome-based treatment strategies in the clinic.
Discover how doctors and patients can recognize and safely manage an overstimulated or misdirected immune response with Dr. Jeffrey S. Weber of NYU Langone Health.
Discover the full potential of genome-based medicine with genomic and genetic testing for cancer risk and tumor assessment with Corrie Painter, Ph.D., and Eliezer Van Allen, M.D.
Discover antibody-based imaging strategies that help doctors visualize patients’ tumors and immune cells in real-time via PET scans.
Dr. Padmanee Sharma of MD Anderson discusses what breakthroughs and advances might lie ahead for the field of cancer immunotherapy in 2020.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
New research, new treatments, and how we’re working toward a future immune to cervical cancer
Ugur Sahin and Ozlem Tureci, two of this year’s CRI Coley Award recipients, are pioneers of the mRNA vaccines helping us confront COVID-19 and cancer.